866-997-4948(US-Canada Toll Free)

United States Drugs for Malaria Market Report 2017

Published By :

QYResearch

Published Date : Jul 2017

Category :

Pharmaceutical

No. of Pages : 103 Pages

In this report, the United States Drugs for Malaria market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Drugs for Malaria in these regions, from 2012 to 2022 (forecast).

United States Drugs for Malaria market competition by top manufacturers/players, with Drugs for Malaria sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi?Aventis
Ajanta Pharma

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Drugs for Malaria for each application, including
Prevention
Treatment
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Drugs for Malaria Market Report 2017
1 Drugs for Malaria Overview
1.1 Product Overview and Scope of Drugs for Malaria
1.2 Classification of Drugs for Malaria by Product Category
1.2.1 United States Drugs for Malaria Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Drugs for Malaria Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Aryl Aminoalcohol Compounds
1.2.4 Antifolate Compounds
1.2.5 Artemisinin Compounds
1.3 United States Drugs for Malaria Market by Application/End Users
1.3.1 United States Drugs for Malaria Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Prevention
1.3.3 Treatment
1.3.4 Other
1.4 United States Drugs for Malaria Market by Region
1.4.1 United States Drugs for Malaria Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Drugs for Malaria Status and Prospect (2012-2022)
1.4.3 Southwest Drugs for Malaria Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Drugs for Malaria Status and Prospect (2012-2022)
1.4.5 New England Drugs for Malaria Status and Prospect (2012-2022)
1.4.6 The South Drugs for Malaria Status and Prospect (2012-2022)
1.4.7 The Midwest Drugs for Malaria Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Drugs for Malaria (2012-2022)
1.5.1 United States Drugs for Malaria Sales and Growth Rate (2012-2022)
1.5.2 United States Drugs for Malaria Revenue and Growth Rate (2012-2022)

2 United States Drugs for Malaria Market Competition by Players/Suppliers
2.1 United States Drugs for Malaria Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Drugs for Malaria Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Drugs for Malaria Average Price by Players/Suppliers (2012-2017)
2.4 United States Drugs for Malaria Market Competitive Situation and Trends
2.4.1 United States Drugs for Malaria Market Concentration Rate
2.4.2 United States Drugs for Malaria Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Drugs for Malaria Manufacturing Base Distribution, Sales Area, Product Type

3 United States Drugs for Malaria Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Drugs for Malaria Sales and Market Share by Region (2012-2017)
3.2 United States Drugs for Malaria Revenue and Market Share by Region (2012-2017)
3.3 United States Drugs for Malaria Price by Region (2012-2017)

4 United States Drugs for Malaria Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Drugs for Malaria Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Drugs for Malaria Revenue and Market Share by Type (2012-2017)
4.3 United States Drugs for Malaria Price by Type (2012-2017)
4.4 United States Drugs for Malaria Sales Growth Rate by Type (2012-2017)

5 United States Drugs for Malaria Sales (Volume) by Application (2012-2017)
5.1 United States Drugs for Malaria Sales and Market Share by Application (2012-2017)
5.2 United States Drugs for Malaria Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Drugs for Malaria Players/Suppliers Profiles and Sales Data
6.1 Cipla
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Drugs for Malaria Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Cipla Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Guilin Pharmaceutical
6.2.2 Drugs for Malaria Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 IPCA Laboratories
6.3.2 Drugs for Malaria Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 IPCA Laboratories Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
6.4.2 Drugs for Malaria Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 GlaxoSmithKline Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Mylan Labs
6.5.2 Drugs for Malaria Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Mylan Labs Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Roche
6.6.2 Drugs for Malaria Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Roche Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Novartis
6.7.2 Drugs for Malaria Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Novartis Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Sanofi?Aventis
6.8.2 Drugs for Malaria Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Sanofi?Aventis Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Ajanta Pharma
6.9.2 Drugs for Malaria Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Ajanta Pharma Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview

7 Drugs for Malaria Manufacturing Cost Analysis
7.1 Drugs for Malaria Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Drugs for Malaria

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Drugs for Malaria Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Drugs for Malaria Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Drugs for Malaria Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Drugs for Malaria Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Drugs for Malaria Sales Volume Forecast by Type (2017-2022)
11.3 United States Drugs for Malaria Sales Volume Forecast by Application (2017-2022)
11.4 United States Drugs for Malaria Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Drugs for Malaria
Figure United States Drugs for Malaria Market Size (K Pcs) by Type (2012-2022)
Figure United States Drugs for Malaria Sales Volume Market Share by Type (Product Category) in 2016
Figure Aryl Aminoalcohol Compounds Product Picture
Figure Antifolate Compounds Product Picture
Figure Artemisinin Compounds Product Picture
Figure United States Drugs for Malaria Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Drugs for Malaria by Application in 2016
Figure Prevention Examples
Table Key Downstream Customer in Prevention
Figure Treatment Examples
Table Key Downstream Customer in Treatment
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Drugs for Malaria Market Size (Million USD) by Region (2012-2022)
Figure The West Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Drugs for Malaria Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Drugs for Malaria Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Drugs for Malaria Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Drugs for Malaria Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Drugs for Malaria Sales Share by Players/Suppliers
Figure 2017 United States Drugs for Malaria Sales Share by Players/Suppliers
Figure United States Drugs for Malaria Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Drugs for Malaria Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Drugs for Malaria Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Drugs for Malaria Revenue Share by Players/Suppliers
Figure 2017 United States Drugs for Malaria Revenue Share by Players/Suppliers
Table United States Market Drugs for Malaria Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Drugs for Malaria Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Drugs for Malaria Market Share of Top 3 Players/Suppliers
Figure United States Drugs for Malaria Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Drugs for Malaria Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Drugs for Malaria Product Category
Table United States Drugs for Malaria Sales (K Pcs) by Region (2012-2017)
Table United States Drugs for Malaria Sales Share by Region (2012-2017)
Figure United States Drugs for Malaria Sales Share by Region (2012-2017)
Figure United States Drugs for Malaria Sales Market Share by Region in 2016
Table United States Drugs for Malaria Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Drugs for Malaria Revenue Share by Region (2012-2017)
Figure United States Drugs for Malaria Revenue Market Share by Region (2012-2017)
Figure United States Drugs for Malaria Revenue Market Share by Region in 2016
Table United States Drugs for Malaria Price (USD/Pcs) by Region (2012-2017)
Table United States Drugs for Malaria Sales (K Pcs) by Type (2012-2017)
Table United States Drugs for Malaria Sales Share by Type (2012-2017)
Figure United States Drugs for Malaria Sales Share by Type (2012-2017)
Figure United States Drugs for Malaria Sales Market Share by Type in 2016
Table United States Drugs for Malaria Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Drugs for Malaria Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Drugs for Malaria by Type (2012-2017)
Figure Revenue Market Share of Drugs for Malaria by Type in 2016
Table United States Drugs for Malaria Price (USD/Pcs) by Types (2012-2017)
Figure United States Drugs for Malaria Sales Growth Rate by Type (2012-2017)
Table United States Drugs for Malaria Sales (K Pcs) by Application (2012-2017)
Table United States Drugs for Malaria Sales Market Share by Application (2012-2017)
Figure United States Drugs for Malaria Sales Market Share by Application (2012-2017)
Figure United States Drugs for Malaria Sales Market Share by Application in 2016
Table United States Drugs for Malaria Sales Growth Rate by Application (2012-2017)
Figure United States Drugs for Malaria Sales Growth Rate by Application (2012-2017)
Table Cipla Basic Information List
Table Cipla Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cipla Drugs for Malaria Sales Growth Rate (2012-2017)
Figure Cipla Drugs for Malaria Sales Market Share in United States (2012-2017)
Figure Cipla Drugs for Malaria Revenue Market Share in United States (2012-2017)
Table Guilin Pharmaceutical Basic Information List
Table Guilin Pharmaceutical Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Guilin Pharmaceutical Drugs for Malaria Sales Growth Rate (2012-2017)
Figure Guilin Pharmaceutical Drugs for Malaria Sales Market Share in United States (2012-2017)
Figure Guilin Pharmaceutical Drugs for Malaria Revenue Market Share in United States (2012-2017)
Table IPCA Laboratories Basic Information List
Table IPCA Laboratories Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure IPCA Laboratories Drugs for Malaria Sales Growth Rate (2012-2017)
Figure IPCA Laboratories Drugs for Malaria Sales Market Share in United States (2012-2017)
Figure IPCA Laboratories Drugs for Malaria Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Drugs for Malaria Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Drugs for Malaria Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Drugs for Malaria Revenue Market Share in United States (2012-2017)
Table Mylan Labs Basic Information List
Table Mylan Labs Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Mylan Labs Drugs for Malaria Sales Growth Rate (2012-2017)
Figure Mylan Labs Drugs for Malaria Sales Market Share in United States (2012-2017)
Figure Mylan Labs Drugs for Malaria Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Roche Drugs for Malaria Sales Growth Rate (2012-2017)
Figure Roche Drugs for Malaria Sales Market Share in United States (2012-2017)
Figure Roche Drugs for Malaria Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Drugs for Malaria Sales Growth Rate (2012-2017)
Figure Novartis Drugs for Malaria Sales Market Share in United States (2012-2017)
Figure Novartis Drugs for Malaria Revenue Market Share in United States (2012-2017)
Table Sanofi?Aventis Basic Information List
Table Sanofi?Aventis Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi?Aventis Drugs for Malaria Sales Growth Rate (2012-2017)
Figure Sanofi?Aventis Drugs for Malaria Sales Market Share in United States (2012-2017)
Figure Sanofi?Aventis Drugs for Malaria Revenue Market Share in United States (2012-2017)
Table Ajanta Pharma Basic Information List
Table Ajanta Pharma Drugs for Malaria Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Ajanta Pharma Drugs for Malaria Sales Growth Rate (2012-2017)
Figure Ajanta Pharma Drugs for Malaria Sales Market Share in United States (2012-2017)
Figure Ajanta Pharma Drugs for Malaria Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Malaria
Figure Manufacturing Process Analysis of Drugs for Malaria
Figure Drugs for Malaria Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Malaria Major Players/Suppliers in 2016
Table Major Buyers of Drugs for Malaria
Table Distributors/Traders List
Figure United States Drugs for Malaria Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Drugs for Malaria Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Drugs for Malaria Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Drugs for Malaria Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Drugs for Malaria Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Drugs for Malaria Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Drugs for Malaria Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Drugs for Malaria Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Drugs for Malaria Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Drugs for Malaria Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Drugs for Malaria Sales Volume Share Forecast by Region (2017-2022)
Figure United States Drugs for Malaria Sales Volume Share Forecast by Region (2017-2022)
Figure United States Drugs for Malaria Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *